Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, Q2 2026
-1,482
Period ended Jun 30, 2026
Change on a year earlier
-44.6%
-2,673 in Q2 2025
History
60 quarters
Since Q3 2008
Sources
51
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net cash used in financing activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -1,482 | -44.6% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,436 | -135.0% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | -1,226 | -12.9% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | -2,853 | -21.9% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | -2,673 | +0.9% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | -4,107 | +140.5% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | -1,407 | -151.1% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2024 | Sep 30, 2024 | -3,651 | +82.1% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | -2,649 | +118.9% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | -1,708 | -107.9% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 2,754 | -362.5% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | -2,005 | -226.3% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | -1,210 | +13.9% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 21,509 | -712.1% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Dec 31, 2022 | -1,049 | -84.0% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,588 | – | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2022 | Jun 30, 2022 | -1,062 | – | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | -3,514 | +81.2% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | -6,558 | +82.7% | Form 10-K (filed 2022-02-16) ↗ |
| Q1 2021 | Mar 31, 2021 | -1,939 | +663.4% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | -3,590 | – | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | -1,798 | – | Form 10-Q (filed 2020-10-29) ↗ |
| Q2 2020 | Jun 30, 2020 | 775 | -112.9% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | -254 | -94.9% | Form 10-Q (filed 2020-05-01) ↗ |
| Q2 2019 | Jun 30, 2019 | -5,992 | +28.9% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | -4,987 | -57.3% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | -3,568 | +67.2% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | -2,580 | +133.1% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | -4,650 | +274.4% | Form 10-Q (filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | -11,692 | +453.9% | Form 10-Q (filed 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | -2,134 | +0.6% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | -1,107 | -290.2% | Form 10-Q (filed 2017-10-26) ↗ |
| Q2 2017 | Jun 30, 2017 | -1,242 | -45.7% | Form 10-Q (filed 2017-07-26) ↗ |
| Q1 2017 | Mar 31, 2017 | -2,111 | -272.0% | Form 10-Q (filed 2017-04-27) ↗ |
| Q4 2016 | Dec 31, 2016 | -2,122 | +130.2% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2016 | Sep 30, 2016 | 582 | -139.9% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | -2,286 | -38,200.0% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2016 | Mar 31, 2016 | 1,227 | -187.8% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2015 | Dec 31, 2015 | -922 | -70.8% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2015 | Sep 30, 2015 | -1,458 | +184.2% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2015 | Jun 30, 2015 | 6 | -99.3% | Form 10-Q (filed 2016-07-29) ↗ |
| Q1 2015 | Mar 31, 2015 | -1,397 | +182.2% | Form 10-Q (filed 2016-05-02) ↗ |
| Q4 2014 | Dec 31, 2014 | -3,162 | -183.1% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2014 | Sep 30, 2014 | -513 | – | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 896 | – | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | -495 | -86.2% | Form 10-Q (filed 2014-04-30) ↗ |
| Q4 2013 | Dec 31, 2013 | 3,807 | -382.6% | Form 10-K (filed 2014-02-24) ↗ |
| Q1 2013 | Mar 31, 2013 | -3,585 | – | Form 10-Q (filed 2013-05-03) ↗ |
| Q4 2012 | Dec 31, 2012 | -1,347 | – | Form 10-K (filed 2013-02-27) ↗ |
| Q1 2011 | Mar 31, 2011 | -2,496 | +333.3% | Form 10-Q (filed 2011-05-10) ↗ |
| Q4 2010 | Dec 31, 2010 | -1,181 | -45.8% | Form 10-K (filed 2011-02-25) ↗ |
| Q3 2010 | Sep 30, 2010 | 1,208 | +2,096.4% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | -683 | -834.4% | Form 10-Q (filed 2010-08-09) ↗ |
| Q1 2010 | Mar 31, 2010 | -576 | -11,620.0% | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | -2,177 | +36.2% | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2009 | Sep 30, 2009 | 55 | -15.4% | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 93 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q1 2009 | Mar 31, 2009 | 5 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2008 | Dec 31, 2008 | -1,598 | – | Form 10-K (filed 2010-03-01) ↗ |
| Q3 2008 | Sep 30, 2008 | 65 | – | Form 10-Q (filed 2009-11-06) ↗ |
Cite this data
StockData. (2026). Amgen Net cash used in financing activities ($M) ($M), quarterly Q3 2008–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_fin_cf
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.